Literature DB >> 26774511

1,25-Dihydroxyvitamin D induces the glutamate transporter SLC1A1 and alters glutamate handling in non-transformed mammary cells.

Sarah Beaudin1, JoEllen Welsh2.   

Abstract

Genomic profiling of immortalized human mammary epithelial (hTERT-HME1) cells identified several metabolic genes, including the membrane glutamate transporter, SLC1A1, as 1,25-dihydroxyvitamin D3 (1,25D) regulated. In these studies we have surveyed the effects of 1,25D on known glutamate transporters and evaluated its impact on cellular glutamate handling. We confirm that expression of SLC1A1 and all of its known transcript variants are significantly upregulated in hTERT-HME1 cells following 1,25D treatment. Expression of the full-length cognate protein, EAAT3, is correspondingly increased in 1,25D treated hTERT-HME1 cells. Under the same conditions, the expression of two other glutamate transporters--SLC1A6 (EAAT4) and SLC1A2 (EAAT2 or GLT-1)--is enhanced by 1,25D while that of SLC1A3 (EAAT1 or GLAST) and SLC7A11 (xCT) is decreased. Glutamate is not essential for growth of hTERT-HME1 cells, and supplemental glutamate (up to 0.5 mM) does not abrogate the growth inhibitory effects of 1,25D. These data suggest that extracellular glutamate is not a major contributor to cellular energy metabolism in hTERT-HME1 cells under basal conditions and that the growth inhibitory effects of 1,25D are not secondary to its effects on glutamate handling. Instead, the effects of 1,25D on glutamate transporters translated to a decrease in cellular glutamate concentration and an increase in media glutamate concentration, suggesting that one or more of these transporters functions to export glutamate in response to 1,25D exposure. The reduced cellular glutamate concentration may also reflect its incorporation into the cellular glutathione (GSH) pool, which is increased upon 1,25D treatment. In support of this concept, the expression of GCLC (which codes for the rate-limiting enzyme in GSH synthesis) and genes which generate reducing equivalents in the form of NADPH (ie, G6PD, PGD, IDH2) are elevated in 1,25D-treated cells. Taken together, these data identify 1,25D as a physiological regulator of multiple membrane glutamate transporters that impacts on overall cellular glutamate handling.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Glutamate; Glutamine; Glutathione; Mammary cells; Vitamin D

Mesh:

Substances:

Year:  2016        PMID: 26774511      PMCID: PMC4779372          DOI: 10.1016/j.mce.2016.01.011

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  33 in total

1.  Microarray analysis of 1,25(OH)₂D₃ regulated gene expression in human primary osteoblasts.

Authors:  Paola Tarroni; Isabella Villa; Emanuela Mrak; Francesca Zolezzi; Michela Mattioli; Claudio Gattuso; Alessandro Rubinacci
Journal:  J Cell Biochem       Date:  2012-02       Impact factor: 4.429

2.  Glutamate enrichment as new diagnostic opportunity in breast cancer.

Authors:  Jan Budczies; Berit M Pfitzner; Balazs Györffy; Klaus-Jürgen Winzer; Cornelia Radke; Manfred Dietel; Oliver Fiehn; Carsten Denkert
Journal:  Int J Cancer       Date:  2014-09-04       Impact factor: 7.396

Review 3.  When and why amino acids?

Authors:  Kresimir Krnjević
Journal:  J Physiol       Date:  2009-10-12       Impact factor: 5.182

4.  Regulation of the glutamate transporter EAAT3 by mammalian target of rapamycin mTOR.

Authors:  Ahmad Almilaji; Tatsiana Pakladok; Anne Guo; Carlos Munoz; Michael Föller; Florian Lang
Journal:  Biochem Biophys Res Commun       Date:  2012-03-29       Impact factor: 3.575

5.  The transcriptomic response of mixed neuron-glial cell cultures to 1,25-dihydroxyvitamin d3 includes genes limiting the progression of neurodegenerative diseases.

Authors:  Marie-France Nissou; Jacques Brocard; Michèle El Atifi; Audrey Guttin; Annie Andrieux; François Berger; Jean-Paul Issartel; Didier Wion
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 6.  The SLC1 high-affinity glutamate and neutral amino acid transporter family.

Authors:  Yoshikatsu Kanai; Benjamin Clémençon; Alexandre Simonin; Michele Leuenberger; Martin Lochner; Martin Weisstanner; Matthias A Hediger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

7.  Metabotropic glutamate receptor-1 as a novel target for the antiangiogenic treatment of breast cancer.

Authors:  Cecilia L Speyer; Ali H Hachem; Ali A Assi; Jennifer S Johnson; John A DeVries; David H Gorski
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

8.  Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer.

Authors:  Malathi Banda; Cecilia L Speyer; Sara N Semma; Kingsley O Osuala; Nicole Kounalakis; Keila E Torres Torres; Nicola J Barnard; Hyunjin J Kim; Bonnie F Sloane; Fred R Miller; James S Goydos; David H Gorski
Journal:  PLoS One       Date:  2014-01-03       Impact factor: 3.240

9.  Isoforms of the neuronal glutamate transporter gene, SLC1A1/EAAC1, negatively modulate glutamate uptake: relevance to obsessive-compulsive disorder.

Authors:  B Porton; B D Greenberg; K Askland; L M Serra; J Gesmonde; G Rudnick; S A Rasmussen; H-T Kao
Journal:  Transl Psychiatry       Date:  2013-05-21       Impact factor: 6.222

Review 10.  Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.

Authors:  Stacey S Willard; Shahriar Koochekpour
Journal:  Int J Biol Sci       Date:  2013-08-09       Impact factor: 6.580

View more
  4 in total

1.  Grainyhead-like 2 Reverses the Metabolic Changes Induced by the Oncogenic Epithelial-Mesenchymal Transition: Effects on Anoikis.

Authors:  Joshua C Farris; Phillip M Pifer; Liang Zheng; Eyal Gottlieb; James Denvir; Steven M Frisch
Journal:  Mol Cancer Res       Date:  2016-04-15       Impact factor: 5.852

Review 2.  The Role of Lipidomics in Autism Spectrum Disorder.

Authors:  Afaf El-Ansary; Salvatore Chirumbolo; Ramesa Shafi Bhat; Maryam Dadar; Eiman M Ibrahim; Geir Bjørklund
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

3.  Vitamin D regulates prostate cell metabolism via genomic and non-genomic mitochondrial redox-dependent mechanisms.

Authors:  Chuck C Blajszczak; Larisa Nonn
Journal:  J Steroid Biochem Mol Biol       Date:  2019-09-28       Impact factor: 4.292

4.  Glutamate transporter SLC1A1 is associated with clear cell renal cell carcinoma

Authors:  Sercan Ergün; Sezgin Güneş; Recep Büyükalpelli; Oğuz Aydın
Journal:  Turk J Med Sci       Date:  2019-04-18       Impact factor: 0.973

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.